The Airway Management Devices Market is estimated to be valued at USD 2.41 Billion in 2024 and is expected to reach USD 3.71 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
To learn more about this report, request sample copy
The demand for emergency care devices is expected to increase owing to the rising incidence of chronic diseases, respiratory diseases, and accidents globally. Additionally, increasing investment by key players to develop advanced airway management devices and growing number of surgical procedures will further aid in the market growth. However, lack of skilled professionals and high costs associated with emergency care devices are factors challenging the market growth.
Increasing Incidence of Preterm Births and Neonatal Respiratory Distress Syndrome
The rising incidence of preterm births and neonatal respiratory distress syndrome has been a major factor driving the demand for airway management devices. Preterm birth, which refers to babies born before 37 weeks of pregnancy, is rising worldwide. According to recent estimates by the World Health Organization, preterm births account for over 1 in 10 infants born globally each year. The highest preterm birth rates are found in North America and Africa. Several factors have contributed to this increasing trend including the rising prevalence of infertility treatments that result in multiple births, lifestyle changes such as delayed childbearing, and chronic conditions like diabetes and hypertension in mothers. For instance, according to ACS estimates released in 2022, around 236,740 Americans were anticipated to receive a lung cancer diagnosis in that year. Suctioning becomes more necessary as the number of lung cancer cases is predicted to rise. Suctioning can help lung cancer patients who are experiencing a respiratory emergency avoid infection. Through the course of the forecast period, this is anticipated to boost the market growth.
Technological Advancements Leading to Product Innovations
The airway management devices market has seen significant progress in recent years, driven by ongoing advancements in product design and development. Key manufacturers have made substantial investments in research and development to bring forth innovative devices boasting enhanced safety, efficacy, and user-friendliness. Among the notable technological innovations are advanced ventilators featuring closed-loop volume guarantee and pressure control, which contribute to improved patient care and outcomes. For instance, in December 2021, the USFDA approved Olympus's Airway Mobile scopes, MAF-TM2, MAF-GM2, and MAF-DM2, allowing medical professionals to carry out a range of upper and lower airway management operations.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients